These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8764667)

  • 61. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
    Martin LP; Jackson DM; Wallsten C; Waszczak BL
    J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine.
    Ouagazzal AM; Kenny PJ; File SE
    Psychopharmacology (Berl); 1999 May; 144(1):54-60. PubMed ID: 10379624
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS; Nunes-De-Souza RL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serotonergic neurons in the median raphe nucleus regulate inhibitory avoidance but not escape behavior in the rat elevated T-maze test of anxiety.
    Dos Santos L; de Andrade TG; Zangrossi H
    Psychopharmacology (Berl); 2005 Jun; 179(4):733-41. PubMed ID: 15619105
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 5-HT1A receptors mediate (+)8-OH-DPAT-stimulation of extracellular signal-regulated kinase (MAP kinase) in vivo in rat hypothalamus: time dependence and regional differences.
    Crane JW; Shimizu K; Carrasco GA; Garcia F; Jia C; Sullivan NR; D'Souza DN; Zhang Y; Van de Kar LD; Muma NA; Battaglia G
    Brain Res; 2007 Dec; 1183():51-9. PubMed ID: 17976547
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze.
    de Paula Soares V; Zangrossi H
    Brain Res Bull; 2004 Aug; 64(2):181-8. PubMed ID: 15342106
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.
    Kõks S; Beljajev S; Koovit I; Abramov U; Bourin M; Vasar E
    Psychopharmacology (Berl); 2001 Jan; 153(3):365-72. PubMed ID: 11271409
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J; Huang XY; Ye ML; Luo CX; Wu HY; Hu Y; Zhou QG; Wu DL; Zhu LJ; Zhu DY
    J Neurosci; 2010 Feb; 30(7):2433-41. PubMed ID: 20164327
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
    Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
    Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serotonin 5-HT
    Nishijo T; Suzuki E; Momiyama T
    J Physiol; 2022 Jul; 600(13):3149-3167. PubMed ID: 35598305
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L; Haj-Dahmane S; Hamon M
    Eur J Pharmacol; 1993 Nov; 249(1):25-35. PubMed ID: 8282017
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of 5-HT in stress, anxiety, and depression.
    Graeff FG; Guimarães FS; De Andrade TG; Deakin JF
    Pharmacol Biochem Behav; 1996 May; 54(1):129-41. PubMed ID: 8728550
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM; Vilaró MT; Mengod G; Artigas F
    J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity.
    Foreman MM; Fuller RW; Rasmussen K; Nelson DL; Calligaro DO; Zhang L; Barrett JE; Booher RN; Paget CJ; Flaugh ME
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1270-81. PubMed ID: 7523657
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional topography of brain serotonergic pathways in the rat.
    Hillegaart V
    Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activation of 5-HT1A and 5-HT7 receptors in the parafascicular nucleus suppresses the affective reaction of rats to noxious stimulation.
    Harte SE; Kender RG; Borszcz GS
    Pain; 2005 Feb; 113(3):405-415. PubMed ID: 15661450
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus in rats.
    Egashira N; Yano A; Ishigami N; Mishima K; Iwasaki K; Fujioka M; Matsushita M; Nishimura R; Fujiwara M
    Brain Res; 2006 Jan; 1069(1):54-62. PubMed ID: 16386718
    [TBL] [Abstract][Full Text] [Related]  

  • 80. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.